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Hypoxia-signalling pathway PCR arrays were used to examine the integrated response of human adipocytes to low O2 tension. Incu-
bation of adipocytes in 1% O2 for 24 h resulted in no change in the expression of 63 of the 84 genes on the arrays, a reduction in expres-
sion of 9 genes (including uncoupling protein 2) and increased expression of 12 genes. Substantial increases (>10-fold) in leptin,
angiopoietin-like protein 4, VEGF and GLUT-1 mRNA levels were observed. The expression of one gene, metallothionein-3 (MT-3),
was dramatically (>600-fold) and rapidly (by 60 min) increased by hypoxia. MT-3 gene expression was also substantially induced by
hypoxia mimetics (CoCl2, desferrioxamine, dimethyloxalylglycine), indicating transcriptional regulation through HIF-1. Hypoxia addi-
tionally induced MT-3 expression in preadipocytes, and MT-3 mRNA was detected in human (obese) subcutaneous and omental adipose
tissue. MT-3 is a highly hypoxia-inducible gene in human adipocytes; the protein may protect adipocytes from hypoxic damage.
 2008 Elsevier Inc.
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Open access under CC BY license.White adipose tissue (WAT) is now recognised as a key
endocrine organ with white adipocytes secreting a multi-
plicity of protein hormones and factors [1–4]. A number
of these adipokines are linked to immunity and inﬂamma-
tion, and a major inﬂammatory response is evident in
WAT in obesity [3,5,6]. This state of inﬂammation is linked
to several of the diseases associated with the obese state,
particularly type 2 diabetes and the metabolic syndrome
[4,6,7]. We have proposed that inﬂammation in adipose tis-
sue in obesity is primarily a consequence of hypoxia in clus-
ters of adipocytes that become distant from the vasculature
as tissue mass expands [3,8]. It has also been suggested that
inﬂammation may be a response to endoplasmic reticulum
stress, or to reactive oxygen species [9–11].
Recent studies on ob/ob, KKAy and diet-induced obese
mice have provided evidence that hypoxia occurs in WAT
in obesity [12–14]. Elevated levels of the hypoxia-inducible0006-291X 2008 Elsevier Inc.
doi:10.1016/j.bbrc.2008.01.036
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Open access under CC BY license.transcription factor subunit, HIF-1a, together with
increased expression of hypoxia-sensitive genes, such as
leptin, in obese mice are also consistent with low O2 tension
in WAT in obesity [12–14]. Cell culture studies have
directly demonstrated that the expression of several genes
encoding inﬂammation-related adipokines, including lep-
tin, PAI-I, VEGF and visfatin, are hypoxia-inducible in
murine adipocytes [12,13,15–17]. Production of adiponec-
tin, which has an anti-inﬂammatory action [18,19], is sup-
pressed, however, by hypoxia [16,20]. Hypoxia has
further been shown to modulate the expression of inﬂam-
mation-related adipokine genes in human adipocytes, par-
ticularly leptin, angiopoietin-like protein 4 and VEGF [20].
The expression of facilitative glucose transporters, notably
GLUT-1, is also induced by low O2 tension in human adi-
pocytes, and this is accompanied by a parallel increase in
glucose uptake [21].
Both themurine and human adipocyte cell culture studies
have employed a selective ‘candidate gene’ approach. To
obtain a more global view of hypoxia-sensitive gene expres-
sion in human adipocytes we have utilised hypoxia-signal-
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identiﬁed a member of the metallothionein family of low
mol. wt., cysteine-rich, proteins, metallothionein-3 (MT-3),
as a highly hypoxia-inducible gene in human adipocytes.
We show that expression of the MT-3 gene is rapidly and
dramatically induced in human adipocytes by hypoxia.Materials and methods
Human adipose tissue and adipocyte cell culture. Subcutaneous and
omental WAT was obtained from 3 (1 male, 2 female) obese subjects (BMI
43 ± 6) undergoing gastroplasty (provided by Dr John Pinkney). Ethical
permission was obtained through the Sefton Ethics Committee; the sub-
jects gave informed consent for the removal of fat samples.
Human subcutaneous preadipocytes were obtained, with culture
media, from Zen-Bio (USA) and cultured as previously [20]. The cells were
from patients with a mean BMI of 25 (average age 41 years). Cells were
trypsinized from a 75 cm2 ﬂask and plated at 40,000/cm2 in a 24-well plate
and maintained in preadipocyte medium containing DMEM/Ham’s F12
(1:1, v/v), 10% fetal calf serum (FCS), 15 mM HEPES, 100 U/ml peni-
cillin, 100 lg/ml streptomycin, and 0.25 lg/ml amphotericin B at 37 C in
a humidiﬁed atmosphere of 95% air/5% CO2. Cells were induced at con-
ﬂuence in diﬀerentiation medium (DM) composed of adipose medium
(AM) supplemented with 0.25 mM isobutyl methylxanthine (IBMX) and
10 lM of a PPARc agonist for 5 days. The cells were cultured with AM
containing DMEM/Ham’s F-12 (1:1, v/v), 3% FCS, 1 lM dexamethasone,
100 U/ml penicillin, 100 lg/ml streptomycin, and 0.25 lg/ml amphotericin
B. The medium was changed every 3 days.
Some preadipocytes were collected at the induction day (day 0), divi-
ded into two groups and incubated under 1% O2 or normoxia (21% O2) for
24 h. Fully diﬀerentiated cells at day 15 post-induction were treated with
hypoxia mimetics or exposed to 1% O2 for up to 24 h. For chemical
hypoxia, 100 lM CoCl2, 150 lM desferrioxamine or 500 lM dimethy-
loxalylglycine was added to the wells. For exposure to hypoxia, the cells
were transferred to a MIC-101 modular incubator chamber (Billups-
Rosenberg, USA), which was ﬂushed with 1% O2/94% N2/5% CO2, sealed,
and placed at 37 C for up to 24 h. Control cells were cultured in a
standard incubator (21% O2/5% CO2). Cells were harvested in Trizol at
the stated time-points. All incubations were in replicates of up to 6 wells.
RNA extraction and cDNA synthesis. Total RNA was isolated using
Trizol, and 1 lg reverse transcribed with a Reverse-iTTM 1ST Strand Syn-
thesis Kit (Abgene, UK) in the presence of anchored oligo dT.
PCR arrays. Human hypoxia signalling pathway RT2 ProﬁlerTM PCR
Arrays (SuperArray, USA) were used to screen the expression of multiple
genes (total 84) in human adipocytes exposed to 1% O2. These arrays
combine the ability to simultaneously screen a number of pathway genes
with the quantitative precision of real-time PCR, using SYBR Green
technology. They were used according to the manufacturer’s protocol on a
Stratagene Mx3005P detector.
RT-PCR. MT-3 primers were synthesized commercially (Eurogentec,
UK): (173 bp product), 50-AGACCTGCCCCTGCCCTTC-30 (forward),
50-TGCTTCTGCCTCAGCTGCC-30 (reverse). RT-PCR was performed
with 2 ll of RT cDNA and speciﬁc primers (0.2 lM of forward and
0.2 lM of reverse) and 1.1 Ready MixTM PCR Master Mix (Abgene) in a
volume of 25 ll. PCR conditions were: 2 min at 94 C for denaturation
followed by 32 cycles for MT-3 and 23 cycles for b-actin of 20 s at 94 C
for denaturation, 30 s at the optimal annealing temperature and 45 s at
72 C for extension, with a ﬁnal elongation step of 10 min at 72 C.
Negative controls were performed without templates. PCR products were
sequenced (Eurogentec) to conﬁrm their identity.
Real-time PCR. Real-time PCR reactions were carried out in a ﬁnal
volume of 12.5 ll consisting of 12.5–50 ng of reverse transcribed cDNA
with optimal concentrations of primers and probe and qPCRTM Core kit
(Eurogentec) in 96-well plates on a Stratagene Mx3005P detector. Primer
and probe sets were synthesized commercially (Eurogentec). TaqMan
probes were labelled with a reporter ﬂuorescent dye (FAM: 6-carboxy-ﬂuorescein) at the 50-end and a ﬂuorescent dye quencher (TAMRA: 6-
carboxy-tetramethyl-rhodamine) at the 30-end. The sequence and con-
centrations of primers and probes, together with the product size were as
previously [20,22,23], except for MT-3. The MT-3 sequences (GenBank
Accession No. NM_005954) were: 50-CTGCCCCTGCCCTTCTGG-30
(forward), 50-TCTCCGCCTTTGCACACAC-30 (reverse), and 50-FAM-
CTTGGCACACTTCTCACACTCCGCAGG-TAMRA-30 (probe). Typ-
ically, the ampliﬁcation started with 2 min at 50 C, 10 min at 95 C, and
then 40 cycles of the following: 15 s at 95 C and 1 min at 60 C.
Human POLR2A was used as reference. Relative quantitation values
were expressed using the 2DDCt method (User bulletin #2, ABI Prism 7700,
Applied Biosystems) as fold changes in the target gene normalized to the
reference gene and related to the expression of the controls. PCR eﬃciency
was close to 100% and samples were analyzed in at least duplicate.
Statistical analysis. Diﬀerences between groups were analyzed by an
unpaired Student’s t-test.Results
PCR arrays
In the ﬁrst experiments, human adipocytes diﬀerentiated
from preadipocytes in culture were incubated for 24 h under
either hypoxic conditions (1% O2) or normoxia (21% O2).
The cells were screened using hypoxia-signalling pathway
PCR arrays. Of the 84 hypoxia-sensitive genes in the arrays,
the mRNA level of 63 (75%) did not signiﬁcantly change
(threshold of >2-fold change at P < 0.05) with hypoxia.
These genes included IL-1a, PPARa and GLUT-4. A signif-
icant reduction in mRNA level was observed with 9 genes
(11%). The largest reduction (>4-fold) was for caspase 1
and HIF-1a, with smaller (2- to 3-fold) falls for the remain-
ing 7 genes, which included glutathione peroxidase 1, cata-
lase and uncoupling protein 2 (Table 1).
The mRNA level of a total of 12 genes (14%) was upreg-
ulated by hypoxia (Table 1). These included leptin (20.9-
fold increase), VEGF (20.7-fold increase), angiopoietin-like
protein 4 (10.5-fold increase), IL-6 (2.9-fold increase) and
GLUT-1 (12.4-fold increase). Other genes which were
upregulated by hypoxia included cytoglobin, IGF-2 and
glucose phosphate isomerase; the level of the mRNA
encoding these genes increased 2- to 4-fold in hypoxia.
One particular gene, metallothionein-3 (MT-3), showed a
dramatic increase in expression in response to hypoxia,
the mRNA level rising by >600-fold.
The acute response to hypoxia was then examined in cells
exposed to low O2 tension for 4 rather than 24 h. No signif-
icant change in mRNA level was evident with 76 of the 84
genes (90%) on the arrays, and no gene showed a signiﬁcant
reduction in mRNA. There was, however, a signiﬁcant
increase in expression with 8 genes (9.5%) and 5 of these,
includingGLUT-1,VEGFand leptin, were increased at both
4 and 24 h. The largest increase was again with MT-3, the
mRNA level being 121-fold higher than in normoxic cells.Metallothionein-3 gene expression
To substantiate the observation from the arrays that the
MT-3 gene is strongly induced in human adipocytes by
Table 1
Genes on hypoxia-signalling pathway PCR arrays whose expression is up- or down-regulated in human adipocytes by hypoxia
Gene Protein Change with hypoxia (fold) P value
Upregulated: 24 h
MT3 Metallothionein-3 614.6 <0.001
LEP Leptin 20.9 <0.001
VEGF Vascular endothelial growth factor 20.7 <0.001
SLC2A1 GLUT-1 (facilitative glucose transporter 1) 12.4 <0.001
ANGPTL4 Angiopoietin-like protein 4 10.5 <0.001
BHLHB2 Basic helix-loop-helix domain containing, class B,2 3.94 <0.001
CYGB Cytoglobin 3.64 <0.001
IL6 Interleukin-6 2.90 <0.01
IGF2 Insulin-like growth factor 2 2.67 <0.02
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 2.67 <0.001
GPI Glucose phosphate isomerase 2.22 <0.001
HIF3A Hypoxia inducible factor 3, a-subunit 2.01 <0.001
Downregulated: 24 h
CASP1 Caspase 1, apoptosis-related cysteine protease 4.44 <0.001
HIF1A Hypoxia inducible factor 1, a-subunit 4.11 <0.001
EPAS1 Endothelial PAS domain protein 1 3.17 <0.002
SSSCA1 Sjogren’s syndrome/sclerodoma autoantigen 1 3.14 <0.02
GPX1 Glutathione peroxidase 1 3.07 <0.05
AGPAT2 1-Acylglycerol-3-phosphate O-acyltransferase 2 2.55 <0.002
CAT Catalase 2.53 <0.02
UCP2 Uncoupling protein 2 2.40 <0.001
PSMB3 Proteasome subunit, beta type, 3 2.15 <0.002
Upregulated: 4 h
MT3 Metallothionein-3 121.0 <0.05
SLC2A1 GLUT-1 (facilitative glucose transporter 1) 4.03 <0.002
VEGF Vascular endothelial growth factor 3.72 <0.001
RPL28 Ribosomal protein L28 3.20 <0.05
ADM Adrenomedullin 3.12 <0.05
BHLHB2 Basic helix-loop-helix domain containing, class B,2 2.45 <0.02
LEP Leptin 2.19 <0.05
HK2 Hexokinase 2 2.01 <0.05
Human adipocytes diﬀerentiated from preadipocytes in culture were incubated under normoxia (21% O2) or hypoxia (1% O2) for 4 or 24 h. Hypoxia-
signalling pathway PCR arrays (Superarray) were used to screen those genes whose expression is hypoxia-sensitive. The genes listed are those where there
was a statistically signiﬁcant (P < 0.05) change of at least 2-fold. The fold changes are derived from 4 groups of normoxic and hypoxic adipocytes at 24 h
and 3 groups at 4 h.
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Only a faint band was observed in normoxia, while a
strong band of the size expected for MT-3 was observed
with cells exposed to hypoxia for 24 h (Fig. 1A). Sequence
analysis conﬁrmed that the band corresponded to human
MT-3 mRNA.
MT-3 gene expression was then examined by RT-PCR
in preadipocytes. MT-3 mRNA was not detected in preadi-
pocytes maintained in normoxia, but a strong signal was
obtained in those incubated in 1% O2 (Fig. 1B). To deter-
mine whether the MT-3 gene is expressed in adipose tissue
in vivo, subcutaneous and omental fat from three obese
patients was examined. MT-3 mRNA was detected by
RT-PCR in both adipose tissue depots, the signal being
strongest in omental fat (Fig. 1C).
The response to hypoxia of MT-2A, another member of
the metallothionein family expressed in human adipocytes
[24], was next compared by real-time PCR using Taqman
probes. MT-3 mRNA level was increased, using this
approach, by 112-fold at 4 h and >1600-fold at 24 h
(Fig. 2A). However, there was minimal change (<2-foldincrease) in MT-2A mRNA level at 4–24 h of exposure to
hypoxia (Fig. 2A).
In view of the substantial increase in MT-3 mRNA fol-
lowing 4 h under hypoxic conditions, a detailed time-
course of the early response to low O2 tension was exam-
ined. During the ﬁrst 45 min in 1% O2, MT-3 mRNA level
remained similar to that of cells under normoxia, but a
major increase occurred between 45 and 60 min; by
60 min MT-3 mRNA increased almost 100-fold and this
increase was sustained over the following 3 h (Fig 2B). Lep-
tin mRNA level, measured for comparison, changed later,
at between 60 and 120 min (Fig. 2B).
In the ﬁnal experiments, the eﬀects of chemically
induced hypoxia on MT-3 gene expression were examined.
Three diﬀerent mimetics were used (CoCl2, desferriox-
amine, dimethyloxalylglycine), each of which leads to the
stabilisation of HIF-1a. Incubation with each hypoxia
mimetic resulted in a substantial increase in MT-3 mRNA
level in the adipocytes, the increase ranging from 400-fold
with CoCl2 to 50-fold in the case of dimethyloxalylglycine
(Fig. 3).
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Fig. 1. MT-3 gene expression in human adipocytes and adipose tissue by
RT-PCR. (A) Eﬀect of hypoxia (1% O2 for 24 h) on MT-3 gene expression
in human adipocytes diﬀerentiated in culture. (B) Eﬀect of hypoxia on
MT-3 gene expression in human preadipocytes. Control cells were
incubated under normoxia (21% O2). Representative gels for three sets
of cells are shown. (C) MT-3 gene expression in human subcutaneous and
omental adipose tissue from three obese subjects.
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Fig. 2. Time-course of hypoxia-induced MT-3 gene expression in human
adipocytes by real-time PCR. Human adipocytes, diﬀerentiated in culture,
were incubated under normoxia (21% O2) or hypoxia (1% O2) for the
stated times. (A) MT-3 and MT-2A mRNA levels relative to normoxic
controls at 4, 8, and 24 h of hypoxia. (B) Eﬀect of acute exposure to
hypoxia on MT-3 and leptin mRNA levels. Results are mean values ± SE
(bars) for 4 groups of adipocytes. *P < 0.05; **P < 0.01; ***P < 0.001,
compared with normoxia.
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The present study has utilised PCR hypoxia-signalling
pathway arrays to explore the integrated response of
human adipocytes to low O2 tension. The arrays allow
the expression of multiple genes to be simultaneously
screened while using real-time PCR for the accurate quan-
tiﬁcation of changes in mRNA level. The majority of the
genes on the arrays did not show any signiﬁcant change
in response to hypoxia. These genes included the insulin-
sensitive glucose transporter, GLUT-4, consistent with
our previous study on glucose transporters [21]. One partic-
ular gene, MT-3, a member of the metallothionein family
of low mol. wt. (6000 Mr), cysteine-rich proteins, was iden-
tiﬁed as being dramatically induced by hypoxia in human
adipocytes. The increase in MT-3 mRNA level was rapid
(by 60 min), as well as very substantial (up to 1600-fold
in 24 h). No other gene on the arrays exhibited such a large
response to hypoxia.
MT-3 is not the only member of theMT family expressed
in white adipocytes. Previous studies have shown that the
MT-1 and MT-2 genes are expressed by rodent adipocytes,
with MT protein being secreted from rat fat cells [25], while
expression of the MT-2A gene has been documented in
human adipocytes [24]. In marked contrast to MT-3,
MT-2A expression was minimally aﬀected by hypoxia.
The key transcription factor in the signalling of the
molecular response to low O2 tension is HIF-1 (hypoxia-
inducible factor 1), which consists of a and b subunits
[26–28]. The studies with the three hypoxia mimetics clearly
implicate the HIF-1 signalling pathway in the hypoxia-
induced expression of MT-3. Each mimetic leads to the sta-bilisation of HIF-1a, through inhibition of the prolyl
hydroxylases which in the presence of O2 instigate the deg-
radation of the transcription factor subunit [29,30]. Thus,
MT-3 appears to be transcriptionally activated by HIF-1
in human adipocytes.
Preadipocytes, as well as adipocytes, exhibit a marked
induction of MT-3 gene expression in response to low O2
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Fig. 3. Eﬀect of hypoxia mimetics on MT-3 gene expression in human
adipocytes. Human adipocytes, diﬀerentiated in culture, were incubated
with CoCl2 (100 lM), desferrioxamine (DFO; 150 lM) or dimethyloxal-
ylglycine (DMOG; 500 lM) for 24 h; control adipocytes (Con) received no
addition. MT-3 mRNA levels were measured by real-time PCR. Results
are mean values ± SE (bars) for 4–6 groups of adipocytes. ***P < 0.001,
compared with control cells.
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previously been observed in human astrocytes [31]. MT-3,
also known as growth inhibitory factor, has been consid-
ered largely as a brain-speciﬁc MT [31,32]. Studies with
neurons have indicated that MT-3 is protective against
toxic challenges and it is suggested that the hypoxia-
induced expression in astrocytes protects the brain from
hypoxic damage [31]. Protection against hypoxic stress
may also be the primary function of MT-3 in adipocytes.
MTs in general, particularly MT-1 and MT-2, have been
implicated in zinc homeostasis, protection against metal
toxicity and oxidative damage, and in stimulating angio-
genesis [32].
The PCR arrays demonstrated that hypoxia also leads
to increased expression of several other adipocyte genes.
These include leptin, VEGF, angiopoietin-like protein 4,
IL-6 and GLUT-1, and this is in agreement with our previ-
ous studies on human adipocytes using a candidate gene
approach [20]. Hypoxia-stimulated expression of these
genes has also been demonstrated in murine adipocytes
[13,15]. The array studies further show that IGF-2 gene
expression in human adipocytes is stimulated by hypoxia,
as is the glycolytic enzyme, glucose phosphate isomerase.
The increase in expression of glucose phosphate isomeraseis indicative of higher rates of glycolysis when O2 is limited.
This would be consistent with our recent report that
hypoxia leads to increased synthesis of GLUT-1, together
with elevated glucose uptake, by human adipocytes [21].
The expression of several genes on the arrays was down-
regulated by hypoxia, and interestingly these include cata-
lase and glutathione peroxidase 1, both of which are
associated with the response to oxidative stress and partic-
ularly the breakdown of hydrogen peroxide. The expres-
sion of caspase 1, an enzyme involved in apoptosis, was
also inhibited, as was the mitochondrial carrier protein,
uncoupling protein 2.
MT-3 mRNA was detected here in human adipose tis-
sue, as well as in adipocytes in culture. Although the
WAT samples were obtained from obese subjects, it is
unclear whether the presence of MT-3 mRNA is indicative
of hypoxia within the tissue in human obesity. Direct evi-
dence for hypoxia in adipose tissue in obesity has recently
been obtained in rodents [12–14], and a growing number of
genes have been shown to be hypoxia-sensitive in adipo-
cytes, both rodent and human. Several of these genes are
linked with the inﬂammatory response and angiogenesis,
consistent with the original hypothesis that inﬂammation
in adipose tissue in obesity is a consequence of localised
hypoxia within the tissue [3].
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